SCM
Soleus Capital Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-22,250
| Closed | -$1.7M | – | 80 |
|
|
2022
Q1 | $1.7M | Sell |
22,250
-79,350
| -78% | -$6.06M | 0.22% | 56 |
|
|
2021
Q4 | $6.11M | Buy |
101,600
+35,600
| +54% | +$2.14M | 0.61% | 33 |
|
|
2021
Q3 | $3.7M | Buy |
+66,000
| New | +$3.7M | 0.58% | 43 |
|
|
2020
Q4 | – | Sell |
-10,200
| Closed | -$613K | – | 75 |
|
|
2020
Q3 | $613K | Sell |
10,200
-2,000
| -16% | -$120K | 0.32% | 53 |
|
|
2020
Q2 | $640K | Buy |
12,200
+5,200
| +74% | +$273K | 0.36% | 49 |
|
|
2020
Q1 | $235K | Buy |
+7,000
| New | +$235K | 0.27% | 41 |
|